Objective: Using the murine sponge model, we investigated the temporal relationship between angiogenesis, leukocyte accumulation and endogenous generation of the pro-inflammatory chemokines CXCL1-3/KC and CCL2/JE. Furthermore, the effects of exogenous administration of these chemokines were studied. Methods: Angiogenesis in the implants was assessed by measuring the hemoglobin content (vascular index) and leukocyte accumulation quantified by evaluating MPO and NAG enzyme activities. Results: A progressive increase in hemoglobin content and in enzymatic activities was observed during the whole period. The levels of CXCL1-3/KC and CCL2/JE in the implants peaked at days 7 and 1, respectively. Exogenous administration of CXCL1-3/KC (100 ng/day intra-implant) applied at days 1-3 resulted in increased neovascularization and macrophage accumulation. Intra-implant injections of CCL2/JE (100 ng/day) also resulted in increased angiogenesis and macrophage accumulation. Conclusions: These results demonstrated that the chemokines, CXCL1-3/KC and CCL2/JE, are generated within the sponge compartment and that neovascularization and inflammatory cells influx can be modulated by exogenous administration of the chemokines.
机构:Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
Bingle, L
Brown, NJ
论文数: 0引用数: 0
h-index: 0
机构:Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
Brown, NJ
Lewis, CE
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, EnglandUniv Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
机构:Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
Bingle, L
Brown, NJ
论文数: 0引用数: 0
h-index: 0
机构:Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England
Brown, NJ
Lewis, CE
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, EnglandUniv Sheffield, Sch Med, Div Genom Med, Tumor Targeting Grp, Sheffield S10 2RX, S Yorkshire, England